.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Merck
Daiichi Sankyo
US Department of Justice
Fish and Richardson
QuintilesIMS
McKinsey
Express Scripts
Johnson and Johnson
Colorcon

Generated: June 23, 2017

DrugPatentWatch Database Preview

EPIFOAM Drug Profile

« Back to Dashboard

What is the patent landscape for Epifoam, and when can generic versions of Epifoam launch?

Epifoam is a drug marketed by Mylan Speciality Lp and is included in one NDA.

The generic ingredient in EPIFOAM is hydrocortisone acetate; pramoxine hydrochloride. There are sixty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate; pramoxine hydrochloride profile page.

Summary for Tradename: EPIFOAM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list53
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EPIFOAM at DailyMed

Pharmacology for Tradename: EPIFOAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp
EPIFOAM
hydrocortisone acetate; pramoxine hydrochloride
AEROSOL, METERED;TOPICAL086457-001Approved Prior to Jan 1, 1982BXRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Moodys
Citi
UBS
Teva
Boehringer Ingelheim
Fuji
Federal Trade Commission
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot